Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $170.16M.
ENTERPRISE VALUE (EV)
$170.16M
Eledon Pharmaceuticals, Inc.
Market Cap
$192.97M
Enterprise Value (EV)
$170.16M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $192.97M | $170.16M |
| Journey Medical Corporation (DERM)vs › | $184.12M | $184.02M |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | $157.73M |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | $142.45M |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | $168.38M |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | $116.19M |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | $127.82M |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | $147.17M |
| Compugen Ltd. (CGEN)vs › | $218.42M | $211.16M |
Market Cap
$192.97M
Total Debt
$0.00
Cash
$22.81M
Enterprise Value
$170.16M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
